Gabapentin
- Product NDC
- 50090-5961
- 11-digit product format
- 500905961
- Labeler code
- 50090
- Product ID
- 50090-5961_63ffaba7-e141-43a3-ad3f-e73e549663aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA090858
- Marketing category
- ANDA
- Marketing start
- 2021-07-15
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 6CW7F3G59X | GABAPENTIN | 60142-96-3 | GABAPENTIN |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5961-0 | 50090596100 | 33 BLISTER PACK in 1 CARTON (50090-5961-0) > 1 CAPSULE in 1 BLISTER PACK | 33 blister pack | 2022-04-14 | 0000-00-00 | No | No | Current |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Gabapentin | A-S Medication Solutions | 2022-04-15 | Human Prescription Drug Label | 1 |